Position in UTHR
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,186,317
+$418,087 QoQ
Shares Held
3,687
+1.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $26,613,103 across 27 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
99,300 | $11,738,253 | |
| 2 | VTRS |
Viatris Inc
|
229,555 | $3,101,288 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
3,687 | $2,186,317 | |
| 4 | ALKS |
Alkermes plc.
|
32,729 | $1,157,297 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
8,514 | $1,121,634 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
12,135 | $920,439 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
38,617 | $801,688 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,509 | $747,034 |
All Filings in UTHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,186,317 | 3,687 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,768,230 | 3,629 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,481,907 | 3,535 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,058,022 | 3,682 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,211,192 | 3,929 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,482,986 | 4,203 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,274,602 | 9,138 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,538,596 | 4,830 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,283,905 | 5,589 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,203,238 | 5,472 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,265,549 | 5,603 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,273,506 | 5,769 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,326,067 | 5,921 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $2,020,601 | 7,266 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,474,453 | 7,042 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,592,690 | 6,759 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,643,575 | 9,161 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,493,563 | 11,540 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,541,482 | 13,769 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,342,556 | 13,057 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,745,127 | 10,433 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,692,154 | 11,148 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,104,233 | 10,933 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,290,828 | 10,668 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $803,684 | 8,475 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||